Editorial Board

Editor-in-Chief

  • Alexander M. M. Eggermont, MD, PhD, University Medical Centre Utrecht, Utrecht, Netherlands

Editorial Office

  • EJC Editorial Office, Elsevier Ltd, The Boulevard, Langford Lane, Kidlington, Oxford, OX5 1GB, , UK

Editor: Basic Science and Preclinical Research

  • Ulrich Keilholz, Dr. med., Charite University Hospital Berlin Centre 10 Charite Comprehensive Cancer Center, Berlin, Germany

Editor: Epidemiology and Prevention

  • Valery E. Lemmens, Comprehensive Cancer Centre South, Eindhoven, Netherlands

Editor: Tumour Immunotherapy

  • Aurelien Marabelle, MD, PhD, Gustave Roussy, Villejuif, France

Editors: Breast Cancer

  • Giuseppe Curigliano, MD, PhD, European Institute of Oncology, Milano, Italy
  • Suzette Delaloge, MD, MSc, Gustave Roussy, Villejuif, France

Editors: Gastrointestinal Cancers

  • Michel Ducreux, Gustave Roussy, Villejuif, France
  • Volker Heinemann, Ludwig Maximilians University Munich, München, Germany

Editor: Genitourinary Cancers

  • Karim Fizazi, MD, PhD, Gustave Roussy, Department of Oncological Medicine, Villejuif, France

Editor: Head and Neck Cancer

  • Jean-Pascal Machiels, University Hospital Saint-Luc, Bruxelles, Belgium

Editor: Hemato-Oncology

  • Roch Houot, Rennes 1 University, Rennes, France

Editor: Lung Cancer

  • Joachim G. Aerts, MD, PhD, Erasmus Medical Center, Rotterdam, Netherlands
  • Martin Schuler, Univ-Prof. Dr. med., University of Duisburg-Essen, Duisburg, Germany

Editor: Gynaecological Cancers

  • Ignace Vergote, KU Leuven University Hospitals Leuven, Leuven, Belgium

Editor: Endocrine, Sarcomas and Other Rare Tumours

  • Hans Gelderblom, Leiden University Medical Center, Leiden, Netherlands

Editor: Melanoma

  • Dirk Schadendorf, University of Duisburg-Essen, Duisburg, Germany

Editor: Neuro-oncology

  • Martin van den Bent, Erasmus MC Cancer Centre, Rotterdam, Netherlands

Editor: Paediatric Oncology

  • Rob Pieters, MD, MSc, PhD, Princess Maxima Center for Pediatric Oncology, Utrecht, Netherlands

Clinical Oncology Editorial Board

  • A.C.J. van Akkooi, M.D, PhD, Melanoma Institute Australia, North Sydney, Australia
  • Richard Baird, University of Cambridge, Cambridge, United Kingdom
  • Raffaele Califano, MD, The Christie NHS Foundation Trust, Manchester, United Kingdom
  • Emiliano Calvo, START International Inc., Madrid-CIOCC, Ctro Integral Oncológico Clara Campal, Hospital Universitario Madrid Norte Sanchinarro, Madrid, Spain
  • Fatima Cardoso, MD, Champalimaud Clinical Centre, Lisboa, Portugal
  • Elisabeth G De Vries, Academic Medical Centre Groningen, Groningen, Netherlands
  • Adam Dicker, Thomas Jefferson University, Philadelphia, Pennsylvania, United States of America
  • Reinhard Dummer, University of Zurich, Zurich, Switzerland
  • Sara Erridge, The University of Edinburgh, Edinburgh, United Kingdom
  • Birgit Geoerger, INSERM U749, Villejuif, France
  • John Haanen, MD, PhD, Amsterdam, Amsterdam, Netherlands
  • Baktiar Hasan, European Organisation for Research and Treatment of Cancer, Brussels, Belgium
  • Jean-Claude Horiot, Institut Multidisciplinaire d'Oncologie, Genolier clinic, Genolier, Switzerland
  • Dirk Jäger, German Cancer Research Center, Heidelberg, Germany
  • Artur Katz, Syrian-Lebanese Hospital, SAO PAULO, Brazil
  • Paul Lorigan, Christie Hospital, Manchester, United Kingdom
  • Yohann Loriot, MD, PhD, INSERM U749, Villejuif, France
  • Christophe Massard, MD, PhD, INSERM U749, Villejuif, France
  • Kerrie McDonald, University of New South Wales, Sydney, New South Wales, Australia
  • Françoise Meunier, Federation of European Academies of Medicine (FEAM), Brussels, Belgium
  • Tony Mok, The Chinese University of Hong Kong, Dept. of Clinical Oncology, Hong Kong, Hong Kong
  • Do-Hyun Nam, Sungkyunkwan University, Jongno-gu, South Korea
  • James Perry, Sunnybrook Research Institute, Toronto, Ontario, Canada
  • Achim Rody, University of Lübeck, Lübeck, Germany
  • Manuela Schmidinger, Medical University of Vienna, Wien, Austria
  • Jean-Charles Soria, INSERM U749, Villejuif, France
  • Silvia Stacchiotti, Fondazione IRCCS Istituto Nazionale Tumori, Cancer Medicine Department, Adult mesenchymal tumour & Rare cancer Medical Oncology Unit, Milano, Italy
  • Cora Sternberg, MD, FACP, Vincenzo Pansadoro Foundation, Roma, Italy
  • Eric Van Cutsem, MD, PhD, KU Leuven, Department of Oncology, Leuven, Belgium
  • Galina Velikova, University of Leeds, Leeds, United Kingdom
  • Eric Winquist, London Health Sciences Centre, London, Ontario, Canada
  • Timothy Yap, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

Basic Science and Preclinical Research Editorial Board

  • Paola Allavena, Humanitas Research Hospital Cellular Immunology Lab, Rozzano, Milan, Italy
  • John Anderson, BA MBBS MRCP PhD, University College London Institute of Child Health, London, United Kingdom
  • Massimo Broggini, Mario Negri Institute for Pharmacological Research, Milano, Italy
  • Christophe Caux, Centre Léon Bérard, Dept. of Medical Oncology, Lyon, France
  • Manel Esteller, M.D., Ph.D., Research Institute Against Leukemia Josep Carreras, Barcelona, Spain
  • Enrico Garattini, Mario Negri Institute for Pharmacological Research, Milano, Italy
  • J.M. Irish, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America
  • John Lunec, Newcastle University, Newcastle Upon Tyne, United Kingdom
  • Antonia Maria Müller, University of Zurich, Zurich, Switzerland
  • Daniel Olive, Aix-Marseille I University, Marseille, France
  • Athanasios Papavassiliou, National and Kapodistrian University of Athens School of Health Sciences, Athens, Greece
  • Giorgio Parmiani, San Raffaele Hospital, Milano, Italy
  • Victoria Sanz-Moreno, King's College London, London, United Kingdom
  • Sheila Singh, McMaster University, Hamilton, Ontario, Canada
  • John Stagg, University of Montreal, Montréal, Quebec, Canada
  • Amaya Virós, Cancer Research UK, Macclesfield, United Kingdom
  • Britta Weigelt, MEMORIAL SLOAN KETTERING CANCER CENTER, New York, New York, United States of America
  • Nadia Zaffaroni, Fondazione IRCCS Istituto Nazionale Tumori, Department of Applied Research and Technological Development, Milano, Italy

Epidemiology and Prevention Editorial Board

  • Philippe Autier, International Prevention Research Institute, Lyon, France
  • Marianne Berwick, , New Mexico, United States of America
  • Nirmala Bhoo Pathy, Kuala Lumpur, Malaysia
  • Paolo Boffetta, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America
  • Cristina Bosetti, Mario Negri Institute for Pharmacological Research, Milano, Italy
  • Emanuele Crocetti, Florence, Italy
  • Christine Friedenreich, MSc, PhD, University of Calgary, Calgary, Alberta, Canada
  • Gemma Gatta, Milan, Milano, Italy
  • Iris Lansdorp-Vogelaar, Erasmus University Rotterdam, Rotterdam, Netherlands
  • Marc Maynadié, University Hospital Centre Dijon Bourgogne, Dijon, France
  • Henrik Møller, King's College London, London, United Kingdom
  • Eleni Petridou, MD, PhD, National and Kapodistrian University of Athens, Athens, Greece
  • Lonneke van de Poll-Franse, Catharina Hospital, Eindhoven, Netherlands
  • Marjanka Schmidt, Antoni van Leeuwenhoek Netherlands Cancer Institute, Amsterdam, Netherlands
  • Isabelle Soerjomataram, International Agency for Research on Cancer, Lyon, France
  • Esther de Vries, Erasmus University Rotterdam, Rotterdam, Netherlands

Paediatric Oncology Editorial Board

  • Christophe Bergeron, Institute of Paediatric Haematology and Oncology, Lyon, France
  • Eric Bouffet, The Hospital for Sick Children, Toronto, Ontario, Canada
  • Mitchell Cairo, MD, New York Medical College, Valhalla, New York, United States of America
  • Guillermo Chantada, Hospital JP Garrahan, Buenos Aires, Argentina
  • Francois Doz, Institute Curie, Paris, France
  • Andrea Ferrari, Foundation IRCCS National Cancer Institute, Milano, Italy
  • Martha A. Grootenhuis, Amsterdam UMC Location AMC, Amsterdam, Netherlands
  • Marry van den Heuvel-Eibrink, Erasmus University Rotterdam, Rotterdam, Netherlands
  • Max van Noesel, Erasmus MC Sophia Children Hospital, Rotterdam, Netherlands
  • Kathy Pritchard-Jones, University College London, London, United Kingdom
  • Lillian Sung, The Hospital for Sick Children, Toronto, Ontario, Ontario, Canada